U.S. Markets closed

Kane Biotech Inc. (KNE.V)


TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.120.00 (0.00%)
At close: 2:30PM EDT
People also watch
ICO.VMBI.VDMA.VMIR.VINT.V

Kane Biotech Inc.

162-196 Innovation Drive
Winnipeg, MB R3T 2N2
Canada
204-453-1301
http://www.kanebiotech.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Mr. Mark Ahrens-Townsend B.Sc. (Eng.) MBAChief Exec. Officer, Pres & Director229.89kN/AN/A
Mr. L. Michael CouttsDirector of Bus. Devel.N/AN/AN/A
Mr. Grant HumphreyVP of SalesN/AN/AN/A
Dr. Tony RomeoChief Scientific Advisor and Member of Scientific Advisory BoardN/AN/AN/A
Mr. P. Marcus Enns B.Comm. (Hons.)VP of Corp. AffairsN/AN/A38
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Kane Biotech Inc., a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms. It develops wound care solutions under the DispersinB and AloSera trademarks; medical device coatings under the Aledex trademark; and pet oral care solutions under the StrixNB and bluestem trademarks. The company also offers its products under the coactive+ and Kane trademarks. In addition, it offers KBI Antibacterial Disinfectant. The company was founded in 2001 and is based in Winnipeg, Canada.

Corporate Governance

Kane Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.